N-Zyme & LGM Pharma Create Novel Pepsin Inhibitor Therapy
18 Nov 2024 //
PRESS RELEASE
New Harbor Capital Portfolio Company LGM Pharma Promotes CFO& CCO
22 Oct 2024 //
PRESS RELEASE
LGM Pharma Expands Its Analytical Testing Services
15 Oct 2024 //
PRESS RELEASE
New Harbor Compleate Recapitalizes LGM For Strategic Growth
01 Oct 2024 //
PRESS RELEASE
LGM Pharma Unveils Enhanced Analytical Testing Services & Expands CDMO Portfolio
22 Mar 2024 //
PRESS RELEASE
BioPharma Connections Adds LGM Pharma as a Strategic Client Partner
25 Jul 2023 //
ACCESSWIRE
Interview with LGM Pharma’s CEO, Prasad Raje
19 Apr 2023 //
PHARMATECH
LGM Pharma Reports Strong Revenues In First Year Of CDMO
15 Mar 2023 //
PRESS RELEASE
Building a Pharmaceutical API Procurement Strategy that Delivers
13 Mar 2023 //
PRESS RELEASE
Quality, Clarity and Speed: An Integrated R&D and Regulatory Approach
03 Mar 2023 //
PRESS RELEASE
LGM Pharma’s Unique Mix of API Sourcing & CDMO Services Is Fueling Robust Growth
16 May 2022 //
PRESS RELEASE
LGM Pharma Launches Standalone Analytical Services
08 Jul 2021 //
PRESS RELEASE
NAI/Merin Hunter Codman negotiates 33,488 sf lease on behalf of Boca Raton’s LGM
29 Jun 2021 //
PRESS RELEASE
LGM Pharma Acquires Pharmaceutical Development & Manufacturing Unit of Nexgen
23 Jul 2020 //
PRESS RELEASE
LGM Pharma Expands Client Service Supporting The Provision of High Quality (APIs)
23 Jun 2019 //
PRESS RELEASE
ORPHANION Partners with API Sourcing LGM to its Niche API Services
18 Mar 2019 //
PRESS RELEASE
LGM Pharma Announces New CEO
28 Mar 2018 //
PRESS RELEASE